The three musketeers: uniting against CLL

被引：0
|
作者：
Kwok, Marwan [1 ,2 ]
Stankovic, Tatjana [1 ]
机构：
[1] Univ Birmingham, Birmingham, W Midlands, England
[2] Queen Elizabeth Hosp Birmingham, Birmingham, W Midlands, England
来源：
BLOOD | 2022年 / 139卷 / 09期
关键词：
OBINUTUZUMAB; VENETOCLAX; RESISTANCE; IBRUTINIB;
D O I：
10.1182/blood.2021014826
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this issue of Blood , Huber et al(1) present results of an important prospective clinical trial, demonstrating that the combination of obinutuzumab, ibrutinib, and venetoclax produces high rates of undetectable measurable residual disease and remarkable 2-year progression-free survival in previously untreated del(17p) or TP53-mutated chronic lymphocytic leukemia (CLL).
引用
收藏
页码：1264 / 1265
页数：2
相关论文
共 50 条
  • [1] Three Musketeers
    Aizenberg, Edna
    REVIEW-LITERATURE AND ARTS OF THE AMERICAS, 2010, (81) : 290 - 292
  • [2] The Three Musketeers
    Sabourin, Lise
    STUDI FRANCESI, 2023, 67 (02) : 471 - 471
  • [3] The Three Musketeers
    Mead, David
    DANCING TIMES, 2018, 109 (1299): : 36 - 37
  • [4] The Three Musketeers
    Watts, George B.
    MODERN LANGUAGE JOURNAL, 1941, 25 (11): : 900 - 901
  • [5] The Three Musketeers
    Senn, R. H.
    MODERN LANGUAGE JOURNAL, 1931, 15 (08): : 650 - 651
  • [6] The Three Musketeers
    Du Mont, Francis M.
    MODERN LANGUAGE JOURNAL, 1932, 16 (04): : 381 - 381
  • [7] THREE MUSKETEERS
    Davis, Lydia
    PARIS REVIEW, 2020, (234): : 199 - 199
  • [8] Three musketeers
    Morse, Karen Walton
    LIBRARY JOURNAL, 2008, 133 (13) : 62 - 62
  • [9] The 'three musketeers'
    Clarke, Mary
    DANCING TIMES, 2007, 97 (1157): : 55 - +
  • [10] The Three Musketeers
    Duetsch, Werner
    CRITICAL STUDIES IN TELEVISION, 2019, 14 (01) : 125 - 128
12345